Publikationen von J. M. Deussing

Dedic, N.; Touma, C.; Romanowski, C. P.; Schieven, M.; Kühne, C.; Ableitner, M.; Lu, A. L.; Holsboer, F.; Wurst, W.; Kimura, M. et al.; Deussing, J. M.: Assessing Behavioural Effects of Chronic HPA Axis Activation Using Conditional CRH-Overexpressing Mice. Cellular and Molecular Neurobiology 32 (5), S. 815 - 828 (2012)

Menke, A.; Arloth, J.; Pütz, B.; Weber, P.; Klengel, T.; Mehta, D.; Gonik, M.; Rex-Haffner, M.; Rubel, J.; Uhr, M. et al.; Lucae, S.; Deussing, J. M.; Müller-Myhsok, B.; Holsboer, F.; Binder, E. B.: Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients. Neuropsychopharmacology 37 (6), S. 1455 - 1464 (2012)

Wefers, B.; Hitz, C.; Hölter, S. M.; Trümbach, D.; Hansen, J.; Weber, P.; Pütz, B.; Deussing, J. M.; de Angelis, M. H.; Roenneberg, T. et al.; Zheng, F.; Alzheimer, C.; Silva, A.; Wurst, W.; Kühn, R.: MAPK Signaling Determines Anxiety in the Juvenile Mouse Brain but Depression-Like Behavior in Adults. PLoS ONE 7 (4), e35035 (2012)

Molander, A.; Vengeliene, V.; Heilig, M.; Wurst, W.; Deussing, J. M.; Spanagel, R.: Brain-Specific Inactivation of the Crhr1 Gene Inhibits Post-Dependent and Stress-Induced Alcohol Intake, but Does Not Affect Relapse-Like Drinking. Neuropsychopharmacology 37 (4), S. 1047 - 1056 (2012)

Rein, M. L.; Deussing, J. M.: The optogenetic (r)evolution. Molecular Genetics and Genomics 287 (2), S. 95 - 109 (2012)

Thoeringer, C. K.; Henes, K.; Eder, M.; Dahlhoff, M.; Wurst, W.; Holsboer, F.; Deussing, J. M.; Moosmang, S.; Wotjak, C. T.: Consolidation of Remote Fear Memories Involves Corticotropin-Releasing Hormone (CRH) Receptor Type 1-Mediated Enhancement of AMPA Receptor GluR1 Signaling in the Dentate Gyrus. Neuropsychopharmacology 37 (3), S. 787 - 796 (2012)

Wang, X.-D.; Labermaier, C.; Holsboer, F.; Wurst, W.; Deussing, J. M.; Müller, M. B.; Schmidt, M. V.: Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1. European Journal of Neuroscience 36 (3), doi: 10.1111/j.1460-9568.2012.08148.x, S. 2360 - 2367 (2012)

Jakubcakova, V.; Flachskamm, C.; Deussing, J. M.; Kimura, M.: Deficiency of corticotropin-releasing hormone type-2 receptor alters sleep responses to bacterial lipopolysaccharide in mice. Brain Behavior and Immunity 25 (8), S. 1626 - 1636 (2011)

Refojo, D.; Schweizer, M.; Kuehne, C.; Ehrenberg, S.; Thoeringer, C.; Vogl, A. M.; Dedic, N.; Schumacher, M.; von Wolff, G.; Avrabos, C. et al.; Touma, C.; Engblom, D.; Schütz, G.; Nave, K. A.; Eder, M.; Wotjak, C. T.; Sillaber, I.; Holsboer, F.; Wurst, W.; Deussing, J. M.: Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1. Science 333 (6051), S. 1903 - 1907 (2011)

Wang, X. D.; Rammes, G.; Kraev, I.; Wolf, M.; Liebl, C.; Scharf, S. H.; Rice, C. J.; Wurst, W.; Holsboer, F.; Deussing, J. M. et al.; Baram, T. Z.; Stewart, M. G.; Müller, M. B.; Schmidt, M. V.: Forebrain CRF(1) Modulates Early-Life Stress-Programmed Cognitive Deficits. Journal of Neuroscience 31 (38), S. 13625 - 13634 (2011)

Fenzl, T.; Romanowski, C. P. N.; Flachskamm, C.; Deussing, J. M.; Kimura, M.: Wake-promoting effects of orexin: Its independent actions against the background of an impaired corticotropine-releasing hormone receptor system. Behavioural Brain Research 222 (1), S. 43 - 50 (2011)

Devigny, C.; Perez-Balderas, F.; Hoogeland, B.; Cuboni, S.; Webb, K.; Deussing, J. M.; Hausch, F.: Biomimetic screening of class B G protein-coupled receptors. Pharmacopsychiatry 44 (6), S. 288 - 288 (2011)

Lerche, K.; Willem, M.; Kleinknecht, K.; Romberg, C.; Konietzko, U.; Nitsch, R. M.; Holsboer, F.; Wurst, W.; Wotjak, C. T.; Deussing, J. M.: Dissecting the role of Corticotropin-releasing hormone receptor type 1 in Alzheimer's Disease. Pharmacopsychiatry 44 (6), S. 299 - 299 (2011)

Moellmann, K. M.; Wurst, W.; Holsboer, F.; Deussing, J. M.: Towards brain-specific functions of histone deacetylases (HDACs) using genetic mouse models. Pharmacopsychiatry 44 (6), S. 301 - 301 (2011)

Walser, S. M.; Dedic, N.; Touma, C.; Floss, T.; Wurst, W.; Holsboer, F.; Deussing, J. M.: TMEM132D-a putative cell adhesion molecule involved in panic disorder. Pharmacopsychiatry 44 (6), S. 310 - 310 (2011)

Czibere, L.; Baur, L. A.; Wittmann, A.; Gemmeke, K.; Steiner, A.; Weber, P.; Pütz, B.; Ahmad, N.; Bunck, M.; Graf, C. et al.; Widner, R.; Kühne, C.; Panhuysen, M.; Hambsch, B.; Rieder, G.; Reinheckel, T.; Peters, C.; Holsboer, F.; Landgraf, R.; Deussing, J. M.: Profiling Trait Anxiety: Transcriptome Analysis Reveals Cathepsin B (Ctsb) as a Novel Candidate Gene for Emotionality in Mice. PLoS ONE 6 (8), e23604 (2011)

Devigny, C.; Perez-Balderas, F.; Hoogeland, B.; Cuboni, S.; Wachtel, R.; Mauch, C. P.; Webb, K. J.; Deussing, J. M.; Hausch, F.: Biomimetic Screening of Class-B G Protein-Coupled Receptors. Journal of the American Chemical Society 133 (23), S. 8927 - 8933 (2011)

Erhardt, A.; Czibere, L.; Roeske, D.; Lucae, S.; Unschuld, P. G.; Ripke, S.; Specht, M.; Kohli, M. A.; Kloiber, S.; Ising, M. et al.; Heck, A.; Pfister, H.; Zimmermann, P.; Lieb, R.; Pütz, B.; Uhr, M.; Weber, P.; Deussing, J. M.; Gonik, M.; Bunck, M.; Kessler, M. S.; Frank, E.; Hohoff, C.; Domschke, K.; Krakowitzky, P.; Maier, W.; Bandelow, B.; Jacob, C.; Deckert, J.; Schreiber, S.; Strohmaier, J.; Nöthen, M.; Cichon, S.; Rietschel, M.; Bettecken, T.; Keck, M. E.; Landgraf, R.; Müller-Myhsok, B.; Holsboer, F.; Binder, E. B.: TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry 16 (6), S. 647 - 663 (2011)

Wang, X. D.; Chen, Y. C.; Wolf, M.; Wagner, K. V.; Liebl, C.; Scharf, S. H.; Harbich, D.; Mayer, B.; Wurst, W.; Holsboer, F. et al.; Deussing, J. M.; Baram, T. Z.; Müller, M. B.; Schmidt, M. V.: Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling. Neurobiology of Disease 42 (3), S. 300 - 310 (2011)

Rammes, G.; Hasenjäger, A.; Sroka-Saidi, K.; Deussing, J. M.; Parsons, C. G.: Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of beta-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Neuropharmacology 60 (6), S. 982 - 990 (2011)